International Conference on Rheumatology and Clinical Research
(ICRCR-26)

10th October 2026 || Ahmedabad - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Rheumatology and Clinical Research (ICRCR), scheduled to be held on 10th October 2026 in Ahmedabad, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Rheumatology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Molecular Diagnostics for Rheumatic Diseases
    This track will explore the latest innovations in molecular diagnostics that enhance the accuracy of rheumatic disease identification. Emphasis will be placed on how these advancements can influence patient management and treatment outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 3 – Good Health and Well-being
  • Track 02 – Translational Research in Rheumatology: Bridging Bench to Bedside
    This session will focus on the translation of laboratory findings into clinical applications in rheumatology. Participants will discuss successful case studies and the challenges faced in implementing translational research in everyday practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Innovative Therapeutic Strategies in Rheumatology
    This track will highlight novel therapeutic approaches for managing rheumatic diseases, including biologics and small molecules. Discussions will include efficacy, safety, and the future of personalized medicine in rheumatology. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Patient-Centered Care in Rheumatology: Best Practices and Challenges
    This session will address the importance of patient-centered care in rheumatology, focusing on strategies that enhance patient engagement and satisfaction. Challenges in implementing these practices in clinical settings will also be examined. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 05 – Immunology and Its Role in Rheumatic Disease Pathogenesis
    This track will delve into the immunological mechanisms underlying rheumatic diseases, highlighting recent discoveries that contribute to our understanding of disease pathogenesis. The implications of these findings for future therapeutic strategies will be discussed. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Biomarker Discovery and Its Impact on Rheumatology
    This session will focus on the identification and validation of biomarkers for rheumatic diseases, exploring their potential to improve diagnosis and treatment monitoring. Participants will share insights on the latest research and clinical applications of biomarkers. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Laboratory Techniques in Rheumatology Research
    This track will provide an overview of cutting-edge laboratory techniques used in rheumatology research, including imaging and molecular biology methods. The session aims to foster collaboration and knowledge exchange among researchers and clinicians. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Disease Management Strategies in Rheumatology
    This session will examine comprehensive disease management strategies for rheumatic conditions, focusing on multidisciplinary approaches that integrate pharmacological and non-pharmacological interventions. Case studies will illustrate effective management plans. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 09 – Clinical Trials and Their Role in Advancing Rheumatology
    This track will discuss the design and implementation of clinical trials in rheumatology, emphasizing the importance of rigorous methodologies and ethical considerations. Participants will review recent trial outcomes and their implications for clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Emerging Trends in Rheumatology Research
    This session will highlight emerging trends and future directions in rheumatology research, including the role of artificial intelligence and big data. Participants will engage in discussions about how these trends can shape the future of patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 11 – Global Perspectives on Rheumatology: Challenges and Opportunities
    This track will provide a platform for discussing the global challenges faced in rheumatology, including disparities in access to care and treatment. Opportunities for international collaboration and knowledge sharing will also be explored. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228